Article
Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Anticancer research - 1 Jan 2000
Albers P, Ko Y, Wardelmann E, Schmidt D, Adam M, Vetter H, Müller S C
Abstract excerpt
BACKGROUND: The aim of this study was to prove the reliability of cytokeratin 18/prostate specific antigen (CK18/PSA) immunocytochemistry to detect tumor cells in the bone marrow of patients with prostate cancer (CaP) compared with a control group without CaP. PATIENTS AND METHODS: In bone marrow aspirates of 34 patients with CaP and 11 control patients without CaP, CK18/PSA immunocytochemistry was performed and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
